Abcuro
Develops immunotherapies that selectively deplete cytotoxic T cells to treat autoimmune diseases
$66MSeries D
Role not disclosedLoading investors…
Loading investors…
Activity from announced rounds
Develops immunotherapies that selectively deplete cytotoxic T cells to treat autoimmune diseases
Runs autonomous AI-driven penetration testing to secure enterprise networks
Relationship intelligence platform for enterprise revenue teams
Developing AI systems to discover and design new materials for clean energy and chipmaking
A leading food technology platform built to make great food more accessible
Building the sovereign infrastructure layer for high-consequence operations and AI-driven systems
Building a safer world by deploying low-cost air defense systems at scale
Provides real-time and historical market data across futures, options, and equities through a unified API
Provides a unified IT operations platform for simplifying work
Develops vertically integrated orbital data centers and launch vehicles for AI compute in space
Develops containerized manufacturing platform for drone systems
Offers business banking accounts, corporate credit cards, transfers, and crypto
Provides AI-powered compliance infrastructure for banks and fintechs
Provides agentic marketing platform for Fortune 500 brands to manage AI-driven marketing channels
AI-native analytics platform that instantly surfaces insights, patterns, and visualizations from connected data
Provides global payments infrastructure for cross-border money movement
Provides a secure enterprise AI platform that helps health systems deploy, govern, and scale AI solutions
Provides AI platform for healthcare finance
AI-native operating system for healthcare practices to automate back office functions
Clinician-led artificial intelligence platform for health plans